Member Info for John117

We could start a ‘just giving’ page :-)

There’s a reason each share has its own forum, otherwise there would only be one forum, and it would be a mess of everybody trying to pump a particular share.

Bushveld looks like a pump and dump, check the all time graph. Wouldn’t touch it with a barge pole.

Well there are forums for each share. It’s not hard.

:-)

I don’t see the average being one test a year per person. If you fly you will break that straight away. Every time you get a cough or sore throat. They need to be cheap. Pile them high sell them cheap.

Wouldn’t be an antibody test....

From memory (not as good as it used to be) the at home trial involves a POC test and a subsequent confirmation test, which must be a PCR. I would guess the first test will be an antigen test. I wouldn’t have thought it would be an antibody test but I’m just guessing

Yes I’m talking about the antigen test that will facilitate our home trial :-)

I’m invested there too, although mainly here. I think the AVCT would be the better option. Just need to get it out. Wouldn’t mind betting we are talking to AVCT.

We need these for the home trial to start.

This is another compelling endorsement of SNG001 possibilities.

“ Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I/-III response, while simultaneously inducing high levels of chemokines needed to recruit effector cells. As a waning immune response would enable sustained viral replication, these findings may explain why serious cases of COVID-19 are more frequently observed in individuals with comorbidities.”

And

“ To determine if SARS-CoV-2 was sensitive to IFN-I, we next treated cells with universal IFN??and assessed viral levels at both an RNA and protein level (Figure S1B-1C). These data demonstrate that the addition of IFN-I resulted in a dramatic reduction of virus replication in agreement with the findings of others (Lokugamage et al., 2020).“

Note : I have only read the first six pages thus far.

A quick 10 minute test is what is needed. The world can get going again with that. Airlines could test everyone before you board a plane for example.

Also you need POC tests.

Midas, am I right in thinking this is now a cash shell valued at 4million or so but with 600k in the bank?

SNG never went below about 50% above their placement price. Give or take a penny or two.

Dreamachine I agree, long term holders need not worry about short term fluctuations.

So yes you are right, it would only apply to IIs that currently hold shares. Obviously they can sell the shares they hold and replenish when the placement shares land. It will only be for a percentage of the placement shares. Also we don’t know how many will just hold, but considering the rise here I would thing it makes a lot of sense to take some profit. I would like to say, for the record, I do not hold any shares in GDR at the moment and I am fully invested in SNG and Avacta right now. So ignore me if you want, and I’m also not in possession of a crystal ball.

Francobrett, all I’m saying is you should not underestimate the placement shares effect on the near term share price. Maybe the company is in a better position than SNG, I know SNG I don’t really know this firm that well. But I do understand numbers and supply and demand. If you don’t want to listen to others then that’s fine. I honestly believe this company will be worth more than £2, maybe a lot more. But my guess right now is it’s heading for £1.10-£1.20 purely because of the placement shares.

We have held up quite well to be fair. Donato you can see the holders on the company website. It’s surprising that it’s Lansdowne that have been selling IMHO.